The prognosis for 115 rheumatic fever patients subsequently receiving regular intramuscular penicillin prophylaxis for at least 5 years was studied. Average follow-up was 9.3 years, and 57 patients were followed for 10 years or longer. Of the 79 patients with acute mitral regurgitation, 70% lost their murmur from 4 days to 8.5 years after it was first heard. This is in contrast to those with acute aortic regurgitation which persisted in 73%. No patient developed mitral or aortic stenosis: this suggests that regular prophylaxis may prevent the development of stenosis. Congestive failure, cardiomegaly, and arrhythmia correlated closely with persistence of murmurs, but increased P-R interval, acute QRS or T-voltage variation or both, and ST-T abnormalities did not.
T HE long-term follow-up studies of patients after acute rheumatic fever deal for the most part with patients, now adults, who never have been or are no longer receiving prophylaxis.1-8 Studies by Jones, Bland, and others were carried out prior to the advent of beta-streptococcal prophylaxis. The morbidity and mortality from acute rheumatic fever (ARF) has changed greatly owing to an unexplained decrease in severity and a reduc-tion in the number of initial attacks and recurrences because of adequate antistreptococcal treatment and prevention. Since rheumatic fever unfortunately has not been eradicated,9 the prognosis for patients receiving prophylaxis and how long prophylaxis should be carried out need to be studied.
Methods The Clinic
Patients are referred to the Rainbow Rheumatic Fever Clinic at Babies and Childrens Hospital from the staff and private inpatient services at the hospital, from other area hospitals, and from area doctors. The registry dates back for 10 years and includes many patients who began to be followed before that time as well as patients who have "graduated" to the adult cardiology clinic or to private internists. Over 90% of the patients receive 1 200,000 units of benzathine penicillin intramuscularly every 28 days. A few patients in the clinic prefer to take penicillin by mouth although intramuscular prophylaxis is advised. Some are allergic to penicillin and take a sulfa drug each day. Excellent Patients periodically receive examinations, electrocardiograms (ECGs), and chest X-rays in the clinic. The frequency of the examinations depends upon the severity of the cardiac problem and the presence of other complaints. All but a few of the patients in the study were examined recently by one of us. These few were examined by an adult cardiologist.
Selection of Patients
Only patients who met the modified Jones criteria for acute rheumatic fever,10 who maintained regular prophylaxis with benzathine penicillin every 28 days, and had been followed for 5 years or longer after their initial episode of ARF were included in the follow-up study. Patients who had rheumatic fever elsewhere were not included unless an excellent history, detailed physical examinations, and laboratory data were available (two patients). Patients who had graduated from the clinic were included if they still received prophylaxis, and we could either call them in for examination or obtain a recent description by a cardiologist of their physical findings.
Unless the auscultatory findings were adequately described during the acute episode and during follow-up, the patient was not included in the study-that is, it had to be clear whether the murmur was one of the significant murmurs of rheumatic fever or a functional murmur. Most 2). Thus only seven patients had no evidence of myocarditis or ECG abnormalities. Sixty-five patients had acute MR without acute AR, one had AR only, and 14 had MR and AR. Additional findings on these patients are summarized in table 2. The P-R interval was considered prolonged if it was greater than the 95th percentile for age.13 The P-R interval in all these patients but one decreased significantly and to normal while in the hospital. ST-T abnormalities included abnormal S-T-segment elevations, flat T waves, or a significant change in the mean T-wave vector. Arrhythmia as used in Of these 14 all but two had elevated Creactive proteins.
Transiency or Persistence of Cardiac Abnormalities
Of the 79 patients with acute MR, 70% lost this murmur anywhere from a few days to 8.5 Circulation, Volume XLV, March 1972 years after it was first noted. The patient whose MR persisted 8.5 years recently had cardiac catheterization and was found to have no evidence of MR on left ventricular angiograms. In a report by Massell and associates' on 484 patients followed as long as 9 years after having ARF, 247 had evidence of valvulitis on admission to the hospital. Nineteen percent lost their murmurs before discharge, and 9 years later only 35% still had their murmurs. The length of time for MR to disappear in this study is shown in table 3. The most common time for MR to disappear was between 1 and 6 months after it was first heard, and the average duration was 1.8 years. In 20 of the total 79 patients with MR, murmurs disappeared more than 2 years, and in six more than 5 years, after the onset of ARF. All of the patients who had MR but lost the murmur have normal findings on physical examinations, ECGs, and X-rays at present. Figure 1 illustrates the disappearance of MR. All 79 patients are included through the first 5 years. Beyond 5 years, at each point the percentage is based on the number followed to that time. The MR murmurs decreased sharply during the first year and by 9 to 10 There were no deaths from rheumatic heart disease among the patients maintained on prophylaxis during the past 10 years, whether or not they met the criteria for the study and were among the 115 reported. (The charts of over 300 patients were reviewed.) The only cardiac deaths occurred in patients who failed to maintain prophylaxis and had recurrent rheumatic fever or subacute bacterial endocarditis, or both.
Subacute Bacterial Endocarditis and Recurrences of Rheumatic Fever
No patient receiving benzathine penicillin developed bacterial endocarditis. Three patients not in the study, one maintained on sulfadiazine and two on oral penicillin, developed this complication.
One patient who had a recurrence of acute rheumatic fever was known to have received her benzathine penicillin every 28 days. She had MR for 7 months after the onset of the initial episode. The murmur disappeared for 1 year and then she again developed definite acute rheumatic fever with MR and chorea. The MR persisted for 15 months after the second episode and has not been heard for the past 10 years.
Four patients were known to have had acute glomerulonephritis some time before their episode of ARF.
Discussion
The Acute Episode and Prevention of Acute Rheumatic Fever
The clinical and laboratory findings during the acute episode were comparable to those in other studies.10' 16, 18 Erythema marginatum and subcutaneous nodules, manifestations which are usually late, were more common in our patients with negative C-reactive protein in the serum than in those with positive Creactive proteins. The lack of "good fidelity" which has been noted by others9 19`21 and by the director of our rheumatic fever clinic prompted the urging of all patients to come in every 28 days for intramuscular penicillin prophylaxis. Because of the interest and persistence of the clinic personnel this has been highly successful. Only one patient receiving benzathine penicillin had a recurrence of rheumatic fever although she had received her penicillin on schedule. A few patients receiving intramuscular prophylaxis did develop streptococcal infections as has been known to occur.
Acute rheumatic fever is well known to occur in adulthood. Gordis and associates22 reported that 18% of all patients hospitalized in Baltimore for ARF between 1960 and 1964 were adults. Grant's2 follow-up of 1,000 rheumatic fever patients included 97 with mitral stenosis. More than half of these 97 reported that they had had recurrences of ARF during adulthood. Leonard and Wenger23 recommended long-term prophylaxis in their study of 577 patients followed an average of 7 years after ARF. Of 265 without carditis initially, 7.2% had recurrences 1 to 18 years later, and of 312 with carditis, 4.2% had recurrences 1 to 20 years later. Because initial episodes were noted up to age 36 and recurrences were noted through the twentieth year after the initial episode, these authors recommended long-term prophylaxis for patients who had no initial evidence of carditis as well as those with carditis.
Regression of Heart Disease
The disappearance of 70% of the MR murmurs and lack of increase in severity of MR in any patient could be expected if further damage to the valve by recurrent rheumatic fever is prevented. In Bland and Jones" series of 1,000 patients followed before the era of prophylaxis only 20% of patients with MR alone lost their murmur by 10 carditis had developed murmurs on later follow-up. Of 347 patients who "recovered unscarred" from their original episode of ARF, 83 (24%) at the end of 10 years and 154 (44%) at the end of 20 years had developed MS. It is unclear whether any of these patients had murmurs during the acute episode which disappeared before discharge from the hospital.
Feinstein and co-workers24 in a later study found that all of the patients who were initially free of carditis during acute rheumatic fever remained free of rheumatic heart disease. Follow-up was up to 11 years (mean, 7.8) and all patients received parenteral benzathine penicillin, oral penicillin, or oral sulfadiazine phophylaxis. Our study confirms this finding and also includes some patients followed more than 15 years. Feinstein's group, however, attributed the lack of development of new heart disease to greater interest in diagnosis and follow-up of ARF since prophylaxis and rheumatic fever clinics have become widespread. He stated "rheumatic heart disease develops insidiously de novo, therefore, in the medically undetected patient with carditis, but not in the p! ient examined during the acute attack and iund to be free of carditis." That is, patients who develop "new" heart disease on later follow-up actually had carditis which was undetected during the acute episode. Thomas17 found that, if patients have no heart disease in the hospital, they will have none at follow-up over periods of 5 to 10 years if there are no recurrences.
Although the lack of development of MS in patients without earlier evidence of carditis may be due to failure to detect carditis earlier, as Feinstein and associates24 discussed, the lack of development of MS in patients with a known history of carditis in our study needs further investigation. MS has been said to take 2 to 20 years to develop after an episode of ARF.5 25 We had 79 patients with known mitral involvement and 29 others with evidence of carditis followed 5 years or longer. Forty-eight of the patients with mitral valve disease were maintained on good prophylaxis and followed 10 years or longer. Since the few Circulation, Volume XLV, March 1972 patients who refused prophylaxis did not attend the clinic, we have no "control" group of patients not receiving prophylaxis. We do know, however, of six patients not receiving prophylaxis who were seen intermittently at this hospital during this period who did develop MS. Four of these six were known to have had recurrent rheumatic fever.
Thomas17 found that MS developed only in patients who had had three or more attacks of rheumatic fever. Feinstein's group24 noted that patients with mitral systolic and diastolic murmurs were more likely to have signs of residual mitral valvular damage if they had recurrent attacks of rheumatic fever than were patients without recurrent attacks. In the Irvington House Study14 of this same group of patients, three had MS on admission to the clinic and five later developed it. It is unclear what type of prophylaxis these patients received, whether they maintained regular prophylaxis, and whether they had more than one episode of ARF.
Bland and Jones6 found that only one third of their rheumatic fever patients who developed MS had clear evidence of recurrent activity. Walsh and associates5 in another study, however, reported on 81 young persons with pure MS. All had definite rheumatic fever at the start of the follow-up study, but the authors emphasized that only one had severe symptoms with the initial episode. Eighty-five percent had definite recurrences. Seventeen percent of the recurrences were manifested by chorea only, 71% were mild rheumatic fever, and 12% were severe rheumatic fever. The authors emphasized that the patients who developed pure MS seem to be those who had mild initial episodes and mild recurrences. Because we found no patient who developed MS We, therefore, suggest that regular prophylaxis should be continued through adulthood. This is based on the following: (1) ARF not uncommonly occurs in adulthood, (2) MS probably develops only after recurrent rheumatic fever which may be subelinical, and (3) MS has not been found to develop in patients who maintained regular prophylaxis. Since prophylaxis in adulthood is not generally advised, an answer could come if a control study were carried out in which patients who have been receiving good prophylaxis are divided into two groups when they reach adulthood. One group would continue to receive intramuscular benzathine penicillin prophylaxis every 28 days, the other would not.
